Osaka, Japan

Hiroyukii Ohno

This inventor holds 3 USPTO granted patents. Top assignee: Ono Pharmaceutical Co., Ltd.. Active years: 2000-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroyukii Ohno. Retrieved from https://idiyas.com/inventor/hiroyukii-ohno

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2000-2002

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Hiroyukii Ohno: Innovator in Pharmaceutical Research

Introduction

Hiroyukii Ohno is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of diseases. With a total of 3 patents to his name, Ohno continues to push the boundaries of medical innovation.

Latest Patents

One of Hiroyukii Ohno's latest patents is a method of treating disease with sulfonylamino acid derivatives. This innovative approach highlights his commitment to developing effective therapeutic solutions. The sulfonylamino acid derivatives he has worked on are crucial in advancing treatment options for various medical conditions.

Career Highlights

Ohno is currently employed at Ono Pharmaceutical Co., Ltd., where he applies his expertise in pharmaceutical research. His work at this esteemed company has allowed him to collaborate with other talented professionals in the industry.

Collaborations

Some of his notable coworkers include Katsuhito Sakaki and Hidekazu Kanazawa. Their combined efforts contribute to the innovative environment at Ono Pharmaceutical Co., Ltd.

Conclusion

Hiroyukii Ohno's contributions to pharmaceutical research and his innovative patents demonstrate his dedication to improving healthcare. His work continues to inspire advancements in medical treatments and showcases the importance of collaboration in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…